Noventure is proud to announce that Medexport has signed an agreement for the distribution of Utipro Plus AF in Kazakhstan We are very grateful for their trust in us. It is really rewarding to expand into new territories with our products!! [...]
Glad to inform that Noventure partnership with the Irish partner Pamex is growing! We are really happy to announce that Pamex is extending their distribution of Utipro Plus AF to the UK. We are very proud for their trust in our company and in our products, and we are sure [...]
We are pleased to announce the launch of UTIPRO® PLUS, our product for uncomplicated UTIs, in Denmark. The product is commercialized under the brand UrinCUR / Utipro plus and it is already present in Sweden, Norway and Finland, distributed as well by our partner RFSU. Utipro® Plus is a medical device intended for [...]
New publication for Utipro® Plus We are pleased to announce the publication of a case series referring about the benefits of Utipro® Plus in some challenging cases of urinary infections. In this new publication, that is the result of a fruitful collaboration among KOLs of international relevance, the product has [...]
We are pleased to inform you about our first #webinar sessions❗ On October 30th we talked about #UTIPROPLUS and its use in uncomplicated #UTIs. Some KOLs presented their experiences with the product and spoke about the latest scientific updates on it and some partners shared the best practices and their [...]
Esposito E et al. Effect of xyloglucan against Escherichia coli extraintestinal urinary tract infection: an in vivo study. Microb Physiol. Published online: Oct 16, 2020. DOI: 10.1159/000510874 Esposito E et al. Effect of xyloglucan against Escherichia coli extraintestinal urinary tract infection: an in vivo study. Microb Physiol. Published online: Oct [...]
Rodriguez-Mañas L. Urinary tract infections in the elderly: a review of disease characteristics and current treatment options. Drugs in Context 2020; 9: 2020-4-13. DOI: 10.7573/dic.2020-4-13. Free PMC article. Rodriguez-Mañas L. Urinary tract infections in the elderly: a review of disease characteristics and current treatment options. Drugs in Context 2020; 9: [...]
Cai T et al. Xyloglucan, hibiscus and propolis to reduce symptoms and antibiotics use in recurrent UTIs: a prospective study. Future Microbiol. 2019 Aug;14:1013-1021. doi: 10.2217/fmb-2019-0145 Cai T et al. Xyloglucan, hibiscus and propolis to reduce symptoms and antibiotics use in recurrent UTIs: a prospective study. Future Microbiol. 2019 Aug;14:1013-1021. [...]
Utipro® Plus AF available for launch We are pleased to announce the availability for launch of a new formulation of UTIPRO® PLUS, our product for uncomplicated UTIs. This version of the product, totally free from animal derivatives, is commercialized under the brand Utipro® Plus AF, whereas AF stands for Advanced Formulation. In [...]
We are pleased to announce the launch of UTIPRO® PLUS, our product for uncomplicated UTIs, in Finland. The product is commercialized over the Finnish territory under the umbrella brand UrinCUR / Utipro plus and it is distributed by RFSU, our partner for the product on the Swedish and Norwegian territory [...]